Reduction of insulin signalling pathway IRS-1/IRS-2/AKT/mTOR and decrease of epithelial cell proliferation in the prostate of glucocorticoid-treated rats

dc.contributor.authorCosta, Maite M. [UNESP]
dc.contributor.authorViolato, Natalia M. [UNESP]
dc.contributor.authorTaboga, Sebastiao R. [UNESP]
dc.contributor.authorGoes, Rejane M. [UNESP]
dc.contributor.authorBosqueiro, José Roberto [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-20T14:01:03Z
dc.date.available2014-05-20T14:01:03Z
dc.date.issued2012-06-01
dc.description.abstractPrevious studies by our research group using a model of insulin resistance induced by dexamethasone (DEX) showed that in the rat ventral prostate there was epithelial and smooth muscle cell atrophy and there were also alterations in fibroblasts. Proteins of the insulin signalling pathway are known to be very important for cell proliferation and development. Thus, we investigated the insulin signalling pathway and epithelial proliferation in the rat ventral prostate in this model and correlated the findings with expression of glucocorticoid (GR) and androgen (AR) receptors. Insulin resistance was induced in adult male Wistar rats by injection of DEX (1 mg/kg, ip for 5 consecutive days), whereas control (CTL) rats received saline. DEX treatment resulted in a significant decrease in body weight, but not in prostate weight. Reductions in insulin receptor 1 (IRS-1) (CTL 1.11 +/- 0.06; DEX 0.85 +/- 0.03), IRS-2 (CTL 0.95 +/- 0.05; DEX 0.49 +/- 0.04), AKT (CTL 0.98 +/- 0.03; DEX 0.78 +/- 0.02), mammalian target of rapamycin (mTOR; CTL 0.65 +/- 0.08; DEX 0.22 +/- 0.05), GR (CTL 1.30 +/- 0.09; DEX 0.57 +/- 0.10) and AR (CTL 1.83 +/- 0.16; DEX 0.55 +/- 0.08) protein levels were observed in the prostate of DEX-treated rats. The expression of the IRa-subunit, phosphoinositide 3-kinase, p-AKT, p70S6K, extracellular signal-regulated kinase (ERK) and p-ERK was not altered. The frequency of AR-positive cells in the epithelium of the prostate decreased in the glucocorticoid-treated group, and the intensity of the reaction for this receptor in the cell nuclei was lower in this group. Furthermore, the treatment with DEX reduced the frequency of proliferating cell nuclear antigen-positive (PCNA) cells 30-fold. This study suggests that the reduction in the insulin signalling pathway proteins IRS-1/IRS-2/AKT/mTOR in the prostate of DEX-treated rats may be associated with the morphological alterations observed previously.en
dc.description.affiliationSão Paulo State Univ Unesp, Dept Phys Educ, Fac Sci, BR-17033360 São Paulo, Brazil
dc.description.affiliationSão Paulo State Univ Unesp, Inst Biosci Letters & Exact Sci, Dept Biol, BR-17033360 São Paulo, Brazil
dc.description.affiliationUnespSão Paulo State Univ Unesp, Dept Phys Educ, Fac Sci, BR-17033360 São Paulo, Brazil
dc.description.affiliationUnespSão Paulo State Univ Unesp, Inst Biosci Letters & Exact Sci, Dept Biol, BR-17033360 São Paulo, Brazil
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.format.extent188-195
dc.identifierhttp://dx.doi.org/10.1111/j.1365-2613.2012.00817.x
dc.identifier.citationInternational Journal of Experimental Pathology. Malden: Wiley-blackwell, v. 93, n. 3, p. 188-195, 2012.
dc.identifier.doi10.1111/j.1365-2613.2012.00817.x
dc.identifier.issn0959-9673
dc.identifier.lattes2423477869556138
dc.identifier.lattes0947193347312157
dc.identifier.orcid0000-0002-0970-4288
dc.identifier.orcid0000-0002-3622-460X
dc.identifier.urihttp://hdl.handle.net/11449/21575
dc.identifier.wosWOS:000303989200004
dc.language.isoeng
dc.publisherWiley-Blackwell
dc.relation.ispartofInternational Journal of Experimental Pathology
dc.relation.ispartofjcr1.938
dc.relation.ispartofsjr0,712
dc.rights.accessRightsAcesso restrito
dc.sourceWeb of Science
dc.subjectcell proliferationen
dc.subjectdexamethasoneen
dc.subjectinsulin resistanceen
dc.subjectinsulin signallingen
dc.subjectventral prostateen
dc.titleReduction of insulin signalling pathway IRS-1/IRS-2/AKT/mTOR and decrease of epithelial cell proliferation in the prostate of glucocorticoid-treated ratsen
dc.typeArtigo
dcterms.licensehttp://olabout.wiley.com/WileyCDA/Section/id-406071.html
dcterms.rightsHolderWiley-blackwell
unesp.author.lattes2423477869556138
unesp.author.lattes0947193347312157[4]
unesp.author.orcid0000-0002-0970-4288[3]
unesp.author.orcid0000-0002-3622-460X[4]
unesp.author.orcid0000-0001-5367-7427[5]
unesp.author.orcid0000-0002-3622-460X[4]
unesp.campusUniversidade Estadual Paulista (Unesp), Faculdade de Ciências, Baurupt
unesp.departmentCiências Biológicas - FCpt
unesp.departmentEducação Física - FCpt

Arquivos

Licença do Pacote

Agora exibindo 1 - 2 de 2
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição:
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: